SARAH MILLER: Open Payments
NPI 1700642246 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 91 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $987 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $232 |
| ABBVIE INC. | 19 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $192 |
| Axsome Therapeutics, Inc. | 4 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $119 |
| Janssen Pharmaceuticals, Inc | 6 | $108 |
| Neurocrine BioSciences, Inc. | 5 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Biogen, Inc. | 3 | $56 |
Products named: ARISTADA, VRAYLAR, CAPLYTA, Auvelity, TRINTELLIX, SPRAVATO, INGREZZA, FANAPT.
Industry payments across PA — which companies pay providers there.
